{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T00:33:34Z","timestamp":1721867614088},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,23]]},"DOI":"10.7759\/cureus.65229","type":"journal-article","created":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T05:11:26Z","timestamp":1721797886000},"source":"Crossref","is-referenced-by-count":0,"title":["Management of Drug-Induced Psoriasis With Secukinumab in a Patient With Schizoaffective Disorder: A Case Report"],"prefix":"10.7759","author":[{"given":"Ibraheim","family":"Ayub","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shehzad","family":"Ayub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2023.115078","article-title":"Epidemiology of mental health comorbidity in patients with psoriasis: an analysis of trends from 1986 to 2019","volume":"321","author":"Liu L","year":"2023","unstructured":"Liu L, Lin NX, Yu YT, et al.. Epidemiology of mental health comorbidity in patients with psoriasis: an analysis of trends from 1986 to 2019. Psychiatry Res. 2023, 321:115078. 10.1016\/j.psychres.2023.115078","journal-title":"Psychiatry Res"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.9708","article-title":"Association between psoriasis and depression: a traditional review","volume":"12","author":"Sahi FM","year":"2020","unstructured":"Sahi FM, Masood A, Danawar NA, Mekaiel A, Malik BH. Association between psoriasis and depression: a traditional review. Cureus. 2020, 12:e9708. 10.7759\/cureus.9708","journal-title":"Cureus"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.4103\/0378-6323.84074","article-title":"Psychiatric morbidity in psoriasis patients: a pilot study","volume":"77","author":"Kumar S","year":"2011","unstructured":"Kumar S, Kachhawha D, Das Koolwal G, Gehlot S, Awasthi A. Psychiatric morbidity in psoriasis patients: a pilot study. Indian J Dermatol Venereol Leprol. 2011, 77:625. 10.4103\/0378-6323.84074","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2011.05071.x","article-title":"Psoriasis, a model of dermatologic psychosomatic disease: psychiatric implications and treatments","volume":"51","author":"Rieder E","year":"2012","unstructured":"Rieder E, Tausk F. Psoriasis, a model of dermatologic psychosomatic disease: psychiatric implications and treatments. Int J Dermatol. 2012, 51:12-26. 10.1111\/j.1365-4632.2011.05071.x","journal-title":"Int J Dermatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1177\/0141076814522033","article-title":"Risk of self-harm and suicide in people with specific psychiatric and physical disorders: comparisons between disorders using English national record linkage","volume":"107","author":"Singhal A","year":"2014","unstructured":"Singhal A, Ross J, Seminog O, Hawton K, Goldacre MJ. Risk of self-harm and suicide in people with specific psychiatric and physical disorders: comparisons between disorders using English national record linkage. J R Soc Med. 2014, 107:194-204. 10.1177\/0141076814522033","journal-title":"J R Soc Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2147\/PTT.S126727","article-title":"Drug-induced psoriasis: clinical perspectives","volume":"7","author":"Balak DM","year":"2017","unstructured":"Balak DM, Hajdarbegovic E. Drug-induced psoriasis: clinical perspectives. Psoriasis (Auckl). 2017, 7:87-94. 10.2147\/PTT.S126727","journal-title":"Psoriasis (Auckl)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.4088\/pcc.v10n0602","article-title":"Lithium and psoriasis: what primary care and family physicians should know","volume":"10","author":"Jafferany M","year":"2008","unstructured":"Jafferany M. Lithium and psoriasis: what primary care and family physicians should know. Prim Care Companion J Clin Psychiatry. 2008, 10:435-9. 10.4088\/pcc.v10n0602","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.4103\/abr.abr_88_21","article-title":"Antidepressants and the risk of psoriasis induction: a case-control study","volume":"12","author":"Sadatmadani SF","year":"2023","unstructured":"Sadatmadani SF, Siadat AH, Iraji F, Alsahebfosoul F. Antidepressants and the risk of psoriasis induction: a case-control study. Adv Biomed Res. 2023, 12:16. 10.4103\/abr.abr_88_21","journal-title":"Adv Biomed Res"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.annder.2022.09.003","article-title":"Psoriasis exacerbation associated with bupropion-induced exanthema","volume":"150","author":"Kluger N","year":"2023","unstructured":"Kluger N. Psoriasis exacerbation associated with bupropion-induced exanthema. Ann Dermatol Venereol. 2023, 150:73-5. 10.1016\/j.annder.2022.09.003","journal-title":"Ann Dermatol Venereol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-017-1411-2","article-title":"Antipsychotic-associated psoriatic rash - a case report","volume":"17","author":"Bujor CE","year":"2017","unstructured":"Bujor CE, Vang T, Nielsen J, Schjerning O. Antipsychotic-associated psoriatic rash - a case report. BMC Psychiatry. 2017, 17:242. 10.1186\/s12888-017-1411-2","journal-title":"BMC Psychiatry"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.596375","article-title":"Association of benzodiazepine receptor agonist use with changes in psoriasis severity in adult population: a population-based study","volume":"12","author":"Pan KT","year":"2021","unstructured":"Pan KT, Li IH, Kao HH, Chen YH, Zhong PX, Kao LT. Association of benzodiazepine receptor agonist use with changes in psoriasis severity in adult population: a population-based study. Front Pharmacol. 2021, 12:596375. 10.3389\/fphar.2021.596375","journal-title":"Front Pharmacol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.4103\/0973-3698.272159","article-title":"Drug-induced psoriasis","volume":"14","author":"Dogra S","year":"2019","unstructured":"Dogra S, Kamat D. Drug-induced psoriasis. Indian J Rheumatol. 2019, 14:S37-43. 10.4103\/0973-3698.272159","journal-title":"Indian J Rheumatol"},{"key":"ref13","article-title":"Psoriasis and associated psychiatric disorders: a systematic review on etiopathogenesis and clinical correlation","volume":"9","author":"Ferreira BI","year":"2016","unstructured":"Ferreira BI, Abreu JL, Reis JP, Figueiredo AM.  Psoriasis and associated psychiatric disorders: a systematic review on etiopathogenesis and clinical correlation. J Clin Aesthet Dermatol. 2016, 9:36-43.","journal-title":"J Clin Aesthet Dermatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1186\/s40345-016-0068-y","article-title":"Lithium side effects and toxicity: prevalence and management strategies","volume":"4","author":"Gitlin M","year":"2016","unstructured":"Gitlin M. Lithium side effects and toxicity: prevalence and management strategies. Int J Bipolar Disord. 2016, 4:27. 10.1186\/s40345-016-0068-y","journal-title":"Int J Bipolar Disord"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2004.05822.x","article-title":"The effect of inositol supplements on the psoriasis of patients taking lithium: a randomized, placebo-controlled trial","volume":"150","author":"Allan SJ","year":"2004","unstructured":"Allan SJ, Kavanagh GM, Herd RM, Savin JA. The effect of inositol supplements on the psoriasis of patients taking lithium: a randomized, placebo-controlled trial. Br J Dermatol. 2004, 150:966-9. 10.1111\/j.1365-2133.2004.05822.x","journal-title":"Br J Dermatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/bdi.13392","article-title":"Breaking tradition: a case report on successfully treating psoriasis in a patient with bipolar disorders using biologics, without discontinuing lithium","volume":"26","author":"Cuniberti F","year":"2024","unstructured":"Cuniberti F, Ribero S, Ortoncelli M, Avetta C, Leombruni P, Oliva F. Breaking tradition: a case report on successfully treating psoriasis in a patient with bipolar disorders using biologics, without discontinuing lithium. Bipolar Disord. 2024, 26:98-102. 10.1111\/bdi.13392","journal-title":"Bipolar Disord"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/275471-management-of-drug-induced-psoriasis-with-secukinumab-in-a-patient-with-schizoaffective-disorder-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T05:11:31Z","timestamp":1721797891000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/275471-management-of-drug-induced-psoriasis-with-secukinumab-in-a-patient-with-schizoaffective-disorder-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,23]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.65229","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7,23]]}}}